Skip to main content

Incidental Hepatic Lesions

  • Chapter
  • First Online:
Liver Disorders
  • 1575 Accesses

Abstract

With the widespread use of radiological studies a greater number of hepatic lesions are identified. Although most of these lesions are benign, a small percentage can be malignant. Hence, a systematic approach and choosing the correct radiological imaging modality can help a physician manage these lesions without the need for exhaustive and time-consuming workup and may prevent a patient from undergoing unnecessary intervention. A number of factors should be considered in the evaluation of a hepatic lesion. These include the patient’s age, gender, medications, such as oral contraceptives or anabolic steroids, their travel history and any previous liver disease or cancers. A triple-phase CT or MRI, which includes a late arterial phase, a portal venous phase, and a delayed venous phase, can help to accurately diagnose a hepatic lesion more than 90 % of the time. Lesions seen in the background of chronic liver disease or cirrhosis should be considered hepatocellular carcinoma until proven otherwise.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 199.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Reed SL. Amebiasis: An update. Clin Inf Dis. 1992;14:385–91.

    Google Scholar 

  2. Chen DS, Sung JL, Sheu JC, Lai MY, How SW, Hsu HC, et al. Serum alpha-fetoprotein in the early stage of human hepatocellular carcinoma. Gastroenterology. 1984;86(6):1404.

    CAS  PubMed  Google Scholar 

  3. Briux et al. Management of hepatocellular carcinoma: an Update, Hepatology, 2011; 53:1020–1022.

    Google Scholar 

  4. Holzapfel K, Breitwieser C, Prinz C, et al. Contrast-enhanced magnetic resonance cholangiography using gadolinium-EOB-DTPA: preliminary experience and clinical applications [in German]. Radiologe. 2007;47:536–44.

    Article  CAS  PubMed  Google Scholar 

  5. Zizka J, Klzo L, Ferda J, et al. Dynamic and delayed contrast enhancement in upper abdominal MRI studies: comparison of gadoxetic acid and gadobutrol. Eur J Radiol. 2007;62:186–91.

    Article  PubMed  Google Scholar 

  6. Hammerstingl R, Huppertz A, Breuer J, et al. Diagnostic efficacy of gadoxetic acid (Primovist)-enhanced MRI and spiral CT for a therapeutic strategy: comparison with intraoperative and histopathologic findings in focal liver lesions. Eur Radiol. 2008;18:457–67.

    Article  PubMed  Google Scholar 

  7. Zech CJ, Herrmann KA, Reiser MF, et al. MR imaging in patients with suspected liver metastases: value of liver-specific contrast agent Gd-EOBDTPA. Magn Reson Med Sci. 2007;6:43–52.

    Article  PubMed  Google Scholar 

  8. Forner A, Vilana R, Ayuso C, Bianchi L, Sole M, Ayuso JR, et al. Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma. Hepatology. 2008;47:97–104.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Syed Rizvi M.D. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Rizvi, S. (2017). Incidental Hepatic Lesions. In: Saeian, K., Shaker, R. (eds) Liver Disorders. Springer, Cham. https://doi.org/10.1007/978-3-319-30103-7_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-30103-7_4

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-30101-3

  • Online ISBN: 978-3-319-30103-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics